FindTrial
Sign In

Study of Manjishtha lepa with Arogyavardhini vati in the management of Pimples.

Randomized control clinical trial to study add on effect of Manjishtha lepa with Arogyavardhini vati in the management of Mukhdushika with special reference to Acne Vulgaris.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046370
Enrollment
64
Registered
2022-10-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris Health Condition 2: L700- Acne vulgaris Health Condition 3: L700- Acne vulgaris

Interventions

None listed

Sponsors

Bharatiya Sanskriti Darshan Trust Ayurved Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1] Patients between age group 16 to 35 years of either gender. 2] Patients having lakshana of mukhdushika (pidaka similar to shalmali kantak , ghana pidaka, medogarbha pidaka, saruj pidaka, srava, twakvaivarnya ). 3] Patients having minimum 2 and more, above mentioned symptoms.

Exclusion criteria

Exclusion criteria: 1] Patient with severe acne vulgaris, who require anti-infective therapies. 2] Patients having Pidakas of other Kshudra Roga and Kushta are excluded 3] Pregnant and lactating mothers

Design outcomes

Primary

MeasureTime frame
To observe and document the add on effect of Manjishtha lepa with Arogyavardhini vati in the management of MukhdushikaTimepoint: assessment on 0th 8th 15th day—

Secondary

MeasureTime frame
To find out adverse effects of Manjishtha lepa if any Timepoint: assessment on 0th 8th 15th day—

Countries

India

Contacts

Public ContactVd Anjali Aniruddha Deshpande

Bharatiya Sanskriti Darshan Trust Ayurved Mahavidyalaya

anjalidesh1610@gmail.com9730069747

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026